Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Malignant Neoplasms
|
1641 | 0.605 | 0.480 | 10 | 129708019 | missense variant | C/T | snv | 0.14 | 0.14 | 0.070 | 1.000 | 7 | 2005 | 2018 | ||||
Primary malignant neoplasm
|
1374 | 0.605 | 0.480 | 10 | 129708019 | missense variant | C/T | snv | 0.14 | 0.14 | 0.070 | 1.000 | 7 | 2005 | 2018 | ||||
Head and Neck Carcinoma
|
118 | 0.605 | 0.480 | 10 | 129708019 | missense variant | C/T | snv | 0.14 | 0.14 | 0.020 | 1.000 | 2 | 2005 | 2018 | ||||
Malignant Head and Neck Neoplasm
|
118 | 0.605 | 0.480 | 10 | 129708019 | missense variant | C/T | snv | 0.14 | 0.14 | 0.020 | 1.000 | 2 | 2005 | 2018 | ||||
Malignant neoplasm of prostate
|
1082 | 0.605 | 0.480 | 10 | 129708019 | missense variant | C/T | snv | 0.14 | 0.14 | 0.020 | 1.000 | 2 | 2005 | 2019 | ||||
Prostate carcinoma
|
1168 | 0.605 | 0.480 | 10 | 129708019 | missense variant | C/T | snv | 0.14 | 0.14 | 0.020 | 1.000 | 2 | 2005 | 2019 | ||||
Bladder Neoplasm
|
281 | 0.605 | 0.480 | 10 | 129708019 | missense variant | C/T | snv | 0.14 | 0.14 | 0.010 | 1.000 | 1 | 2005 | 2005 | ||||
Carcinoma of bladder
|
309 | 0.605 | 0.480 | 10 | 129708019 | missense variant | C/T | snv | 0.14 | 0.14 | 0.010 | 1.000 | 1 | 2005 | 2005 | ||||
Malignant neoplasm of urinary bladder
|
316 | 0.605 | 0.480 | 10 | 129708019 | missense variant | C/T | snv | 0.14 | 0.14 | 0.010 | 1.000 | 1 | 2005 | 2005 | ||||
Xeroderma Pigmentosum, Complementation Group D
|
111 | 0.605 | 0.480 | 10 | 129708019 | missense variant | C/T | snv | 0.14 | 0.14 | 0.010 | 1.000 | 1 | 2005 | 2005 | ||||
Colorectal Carcinoma
|
1962 | 0.605 | 0.480 | 10 | 129708019 | missense variant | C/T | snv | 0.14 | 0.14 | 0.030 | 1.000 | 3 | 2006 | 2014 | ||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.605 | 0.480 | 10 | 129708019 | missense variant | C/T | snv | 0.14 | 0.14 | 0.030 | 1.000 | 3 | 2006 | 2014 | ||||
Breast Carcinoma
|
2793 | 0.605 | 0.480 | 10 | 129708019 | missense variant | C/T | snv | 0.14 | 0.14 | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||
Endometrial Carcinoma
|
326 | 0.605 | 0.480 | 10 | 129708019 | missense variant | C/T | snv | 0.14 | 0.14 | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||
Malignant neoplasm of breast
|
3417 | 0.605 | 0.480 | 10 | 129708019 | missense variant | C/T | snv | 0.14 | 0.14 | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||
Malignant neoplasm of endometrium
|
197 | 0.605 | 0.480 | 10 | 129708019 | missense variant | C/T | snv | 0.14 | 0.14 | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||
Malignant neoplasm of pancreas
|
277 | 0.605 | 0.480 | 10 | 129708019 | missense variant | C/T | snv | 0.14 | 0.14 | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||
Pancreatic carcinoma
|
322 | 0.605 | 0.480 | 10 | 129708019 | missense variant | C/T | snv | 0.14 | 0.14 | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||
Neoplasms
|
1644 | 0.605 | 0.480 | 10 | 129708019 | missense variant | C/T | snv | 0.14 | 0.14 | 0.020 | 1.000 | 2 | 2007 | 2010 | ||||
Cervix carcinoma
|
283 | 0.605 | 0.480 | 10 | 129708019 | missense variant | C/T | snv | 0.14 | 0.14 | 0.010 | 1.000 | 1 | 2007 | 2007 | ||||
Colon Carcinoma
|
275 | 0.605 | 0.480 | 10 | 129708019 | missense variant | C/T | snv | 0.14 | 0.14 | 0.010 | 1.000 | 1 | 2007 | 2007 | ||||
Malignant tumor of colon
|
688 | 0.605 | 0.480 | 10 | 129708019 | missense variant | C/T | snv | 0.14 | 0.14 | 0.010 | 1.000 | 1 | 2007 | 2007 | ||||
Biliary Tract Cancer
|
11 | 0.605 | 0.480 | 10 | 129708019 | missense variant | C/T | snv | 0.14 | 0.14 | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||
Familial multiple trichoepitheliomata
|
32 | 0.605 | 0.480 | 10 | 129708019 | missense variant | C/T | snv | 0.14 | 0.14 | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||
Glioma
|
353 | 0.605 | 0.480 | 10 | 129708019 | missense variant | C/T | snv | 0.14 | 0.14 | 0.040 | 1.000 | 4 | 2009 | 2018 |